Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Sonoma Pharmaceuticals, Inc. (SNOA) had Revenue of $14.29M for the most recently reported fiscal year, ending 2025-03-31.

Quarterly Annual

Figures for fiscal year ending 2025-03-31

Income Statement Financials
Revenue	$14.29M
Net Income	$-3.46M
Cost of Goods Sold	$8.82M
Gross Profit	$5.46M
Operating Expenses	$18.00M
Operating Income	$-3.71M
Non-Operating Income/Expense	$0.80M
Pre-Tax Income	$-2.91M
Normalized Pre-Tax Income	$-2.91M
Income after Taxes	$-3.46M
Income from Continuous Operations	$-3.46M
Consolidated Net Income/Loss	$-3.46M
Normalized Income after Taxes	$-3.46M
EBIT	$-3.71M
EBITDA	$-3.57M
Weighted-Average Shares Outstanding (Basic)	1.24M
Weighted-Average Shares Outstanding (Diluted)	1.24M
Earnings per Share (EPS) (Basic)	$-2.79
Earnings per Share (EPS) (Diluted)	$-2.79
Balance Sheet Financials
Current Assets	$12.65M
Property, Plant, and Equipment	$0.23M
Long-Term Assets	$1.04M
Total Assets	$13.69M
Current Liabilities	$4.10M
Long-Term Debt	--
Long-Term Liabilities	$5.19M
Total Liabilities	$9.28M
Common Equity	$4.41M
Tangible Shareholders Equity	$4.41M
Shareholders Equity	$4.41M
Common Shares Outstanding	1.63M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-0.09M
Cash Flow from Investing Activities	$-0.08M
Cash Flow from Financial Activities	$3.03M
Beginning Cash	$3.13M
End Cash	$5.37M
Increase/Decrease in Cash	$2.25M
Stock-Based Compensation	$0.22M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.09
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	--
Debt to Equity Ratio	0.05
Gross Margin	38.25%
Operating Margin	-25.97%
EBIT Margin	-25.97%
EBITDA Margin	-25.00%
Pre-Tax Profit Margin	-20.35%
Profit Margin	-24.20%
Free Cash Flow	$-0.17M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.04
Inventory Turnover	3.03
Receiveable Turnover	6.40
Days Sales in Receivables	57.02
Return on Equity	-78.37%
Return on Tangible Equity	-78.37%
Return on Assets	-25.25%
Return on Investments	-78.37%
Book Value Per Share	$2.70
Free Cash Flow per Share	$-0.14
Operating Cash Flow per Share	$-0.07

Data from Zacks Investment Research, Inc.